Association of education and feedback on hypertension management with risk for stroke and cardiovascular disease

References

• Brunström M, Carlberg B. Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern Med. 2018;178(1):28–36.
   PubMed Web of Science ®Google Scholar
• Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs-overview and meta-analyses. J Hypertens. 2015;33(2):195–211.
   PubMed Web of Science ®Google Scholar
• Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387(10017):435–443.
   PubMed Web of Science ®Google Scholar
• Brunström M, Carlberg B. Lower blood pressure targets: to whom do they apply? Lancet. 2016;387(10017):405–406.
   PubMed Web of Science ®Google Scholar
• Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923–1994.
   PubMed Web of Science ®Google Scholar
• Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959–968.
   PubMed Web of Science ®Google Scholar
• Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015. JAMA. 2017;317(2):165–182.
   PubMed Web of Science ®Google Scholar
• (NCD-RisC) NRFC. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387:1513–1530.
   PubMed Web of Science ®Google Scholar
• Milman T, Joundi RA, Alotaibi NM, et al. Clinical inertia in the pharmacological management of hypertension: a systematic review and meta-analysis. Medicine (Baltimore. 2018;97(25):e11121.
   PubMed Web of Science ®Google Scholar
• Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825–834.
   PubMed Web of Science ®Google Scholar
• Brunström M, Dahlström J, Lindholm LH, et al. From efficacy in trials to effectiveness in clinical practice: the Swedish stroke prevention study. Blood Press. 2016;25(4):206–211.
   PubMed Web of Science ®Google Scholar
• Brunström M, Ng N, Dahlström J, et al. Association of physician education and feedback on hypertension management with patient blood pressure and hypertension control. JAMA Netw Open. 2020;3(1):e1918625.
   PubMed Web of Science ®Google Scholar
• Persson M, Bohlin J, Eklund P. Development and maintenance of guideline-based decision support for pharmacological treatment of hypertension. Comput Methods Programs Biomed. 2000;61(3):209–219.
   PubMed Web of Science ®Google Scholar
• Persson M, Mjörndal T, Carlberg B, et al. Evaluation of a computer-based decision support system for treatment of hypertension with drugs: retrospective, nonintervention testing of cost and guideline adherence. J Intern Med. 2000;247(1):87–93.
   PubMed Web of Science ®Google Scholar
• 1999 World health Organization-International society of hypertension guidelines for the management of hypertension. Guidelines subcommittee. J Hypertens. 1999; 17:151–183.
   PubMed Web of Science ®Google Scholar
• Norberg M, Wall S, Boman K, et al. The Vasterbotten intervention programme: background, design and implications. Global Health Action. 2010;3(1):4643.
   PubMed Web of Science ®Google Scholar
• Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the swedish national inpatient register. Bmc Public Health. 2011;11:450.
   PubMed Web of Science ®Google Scholar
• Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758–764.
   PubMed Web of Science ®Google Scholar
• Eriksson A, Stenlund H, Ahlm K, et al. Accuracy of death certificates of cardiovascular disease in a community intervention in Sweden. Scand J Public Health. 2013;41(8):883–889.
   PubMed Web of Science ®Google Scholar
• Glynn LG, Murphy Aw Smith Sm Schroeder K, Fahey T. Interventions used to improve control of blood pressure in patients with hypertension. Cochrane Database Syst Rev. 2010;3:CD005182.
   Google Scholar
• Jaffe MG, Lee GA, Young JD, et al. Improved blood pressure control associated with a large-scale hypertension program. JAMA. 2013;310(7):699–705.
   PubMed Web of Science ®Google Scholar
• Go AS, Bauman MA, Coleman King SM, Centers for Disease Control and Prevention, et al. An effective approach to high blood pressure control: a science advisory from the American heart association, the American college of cardiology, and the centers for disease control and prevention. Hypertension. 2014;63(4):878–885.
   PubMed Web of Science ®Google Scholar
• McAlister FA, Feldman RD, Wyard K, CHEP Outcomes Research Task Force, et al. The impact of the Canadian hypertension education programme in its first decade. Eur Heart J. 2009;30(12):1434–1439.
   PubMed Web of Science ®Google Scholar
• Machline-Carrion MJ, Soares RM, Damiani LP, BRIDGE Cardiovascular Prevention Investigators, et al. Effect of a multifaceted quality improvement intervention on the prescription of evidence-based treatment in patients at high cardiovascular risk in Brazil: the BRIDGE cardiovascular prevention cluster randomized clinical trial. JAMA Cardiol. 2019;4(5):408–417.
   PubMed Web of Science ®Google Scholar
• Liddy C, Hogg W, Singh J, et al. A real-world stepped wedge cluster randomized trial of practice facilitation to improve cardiovascular care. Implement Sci. 2015; 10:150.
   PubMed Web of Science ®Google Scholar
• Shelley DR, Gepts T, Siman N, et al. Cardiovascular disease guideline adherence: an RCT using practice facilitation. Am J Prev Med. 2020;58(5):683–690.
   PubMed Web of Science ®Google Scholar
• Andersson T, Pikkemaat M, Schiöler L, et al. Country of birth and mortality risk in hypertension with and without diabetes: the swedish primary care cardiovascular database. J Hypertens. 2020;39(6):1155–1162.
   Google Scholar
• Eliasson M, Eriksson M, Lundqvist R, et al. Comparison of trends in cardiovascular risk factors between two regions with and without a community and primary care prevention programme. Eur J Prev Cardiol. 2018;25(16):1765–1772.
   PubMed Web of Science ®Google Scholar
• Blomstedt Y, Norberg M, Stenlund H, et al. Impact of a combined community and primary care prevention strategy on all-cause and cardiovascular mortality: a cohort analysis based on 1 million person-years of follow-up in västerbotten county, Sweden, during 1990-2006. BMJ Open. 2015;5(12):e009651.
   PubMed Web of Science ®Google Scholar
• Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data Meta-analysis. PLoS Med. 2017;14(9):e1002389.
   PubMed Web of Science ®Google Scholar